US78464A8707 - ETF
SPDR S&P BIOTECH ETF
NYSEARCA:XBI (5/3/2024, 7:27:04 PM)
After market: 90.26 +0.28 (+0.31%)89.98
+1.64 (+1.86%)
The SPDR SP Biotech ETF seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the SP Biotechnology Select Industry Index.
SPDR S&P BIOTECH ETF
Many fortunes have been made with a fortuitous investment in a biotech stock at the right time. That time might be now.
Healthcare stocks have been some of the top performers in 2024, and thanks to the potential of AI, these names will just keep heating up.
These ETFs are easy, low-cost ways to invest in certain themes.
Some of the best opportunities can be found in dips in some of the top biotech stocks to buy. In fact, here are three.
The biotech ETFs have been under serious pressure in recent years. Newfound momentum and looming lower rates could spark a comeback.
Here you can normally see the latest stock twits on XBI, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits: